DOV A MD GOLDSTEIN
CIK 1120478 · Chief Financial Officer · last filed 2026-04-24
DOV A MD GOLDSTEIN is a Chief Financial Officer who has filed 62 SEC Form 4 insider transactions across 9 companies since 2012. The most recent filing shows the insider exercised options covering $15.5K of BIOA on Apr 24, 2026. Across all open-market trades the lifetime net is −$37.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.51M
9
62
-$37.15M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIOA | Chief Financial Officer | 36,575 | $18.04 | $659.8K | -$531.8K | 7 | 2026-04-24 |
| COYA | Director | 27,557 | $4.74 | $130.6K | $0 | 6 | 2026-01-06 |
| GANX | Director | — | $1.68 | — | $0 | 4 | 2025-06-25 |
| NeuBase Therapeutics, Inc. (NBSE) Delisted | Director | 30,000 | $0.38 | $11.3K | $158.0K | 7 | 2022-09-12 |
| ADMA | Director | 7,500 | $8.21 | $61.6K | $0 | 8 | 2020-05-01 |
| ESPR | Director | 1,162,814 | $3.15 | $3.66M | -$53.53M | 11 | 2018-06-08 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Director | 95 | — | — | $1.39M | 14 | 2017-03-09 |
| Loxo Oncology, Inc. (LOXO) Delisted | CFO and Treasurer | 3,515,207 | — | — | $5.37M | 2 | 2015-04-03 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Director | 2,019,713 | — | — | $10.00M | 1 | 2012-07-25 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-24 | BIOA | Exer (M) | +3,542 | $15.5K | EDGAR |
| 2026-03-03 | BIOA | Exer (M) | +3,542 | $15.5K | EDGAR |
| 2026-02-19 | BIOA | Grant (A) | — | $0 | EDGAR |
| 2026-02-03 | BIOA | Exer (M) | +3,541 | $15.5K | EDGAR |
| 2026-01-21 | BIOA | Exer (M) | +3,542 | $15.5K | EDGAR |
| 2026-01-15 | BIOA | Mixed | — | -$305.3K | EDGAR |
| 2026-01-06 | COYA | Grant (A) | — | $0 | EDGAR |
| 2025-08-19 | COYA | Exer (M) | +17,557 | $19.1K | EDGAR |
| 2025-06-25 | GANX | Grant (A) | — | $0 | EDGAR |
| 2025-02-25 | COYA | Grant (A) | — | $0 | EDGAR |